Acasă › Cancer pulmonar cu celule non-pătrate › Illinois › Galesburg
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Galesburg, IL
11 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Galesburg (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
În curs de recrutareFaza 3
- Illinois CancerCare-Galesburg, Galesburg
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Illinois CancerCare-Galesburg, Galesburg
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
În curs de recrutareFaza 2
- Illinois CancerCare-Galesburg, Galesburg
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 3
- Illinois CancerCare Galesburg, Galesburg
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Illinois CancerCare - Galesburg, Galesburg
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
În curs de recrutareFaza 2
- Illinois CancerCare-Galesburg, Galesburg
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Illinois CancerCare-Galesburg, Galesburg
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Illinois CancerCare-Galesburg, Galesburg
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- Illinois CancerCare-Galesburg, Galesburg
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Illinois CancerCare-Galesburg, Galesburg
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- Illinois CancerCare-Galesburg, Galesburg
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Galesburg
- Cancer pulmonar9 studii
- Cancer colorectal7 studii
- Cancer de prostată6 studii
- Cancer de sân5 studii
- Carcinom cu celule scuamoase de cap și gât5 studii
- Cancer pancreatic4 studii
- Leucemie mieloasă acută4 studii
- Cancer de colon4 studii
- Melanom4 studii
- Cancer hipofaringian4 studii
- Cancer laringian4 studii
- Cancer oral4 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.